IPSC

Century Therapeutics Inc

2.95
-0.08 (-2.64%)

Century Therapeutics Inc. (IPSC) Fundamentals

Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
SHARE INFORMATION
Market Cap$ 180,529,876
Shares Outstanding59,580,817
Float23,880,000
Percent Float40.08%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 1,720,000
Latest Fiscal EPS$ -0.53
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions193
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months1,236,797
Institutional Holdings Percent57.8%
Institutional Sold Previous 3 Months3,687,157
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months2,998,994
Insider Holdings Percent2.6
Insider Sold Previous 3 Months144,911
Insider Shares Owned1,539,680
TRADING INFO
52 Week High$ 14.00
52 Week Low$ 2.81
52 Week High Change$ -63.89
21 Day Moving Average$ 3.224
21 Day Extended Moving Average$ 3.23
50 Day Moving Average$ 3.2825
50 Day Extended Moving Average$ 3.474
200 Day Moving Average$ 6.8729
200 Day Extended Moving Average$ 6.3558
10 Day Average Volume76,422
20 Day Average Volume72,122
30 Day Average Volume68,760
50 Day Average Volume101,602
Alpha-0.083453
Beta0.5886
Standard Deviation0.150069
R20.049583
7 Day Price Change$ -0.18
7 Day Percent Change-5.61%
21 Day Price Change$ -0.07
21 Day Percent Change-2.26%
30 Day Price Change$ -0.14
30 Day Percent Change-4.42%
Month to Date Price Change$ -0.10
Month to Date Percent Change-3.19%
Quarter to Date Price Change$ -0.44
Quarter to Date Percent Change-12.68%
180 Day Price Change$ -7.50
180 Day Percent Change-71.23%
200 Day Price Change$ -7.26
200 Day Percent Change-70.55%
Year to Date Price Change$ -2.10
Year to Date Percent Change-40.94%

Century Therapeutics Inc. (IPSC) Key Ratios

PROFITABILITY
EBIT Margin-2,095.8%
EBITDA Margin-1,919.8%
Pre-Tax Profit Margin-4,484.1%
Profit Margin Count-18.18%
Gross Margin38.2%
Profit Margin TOT-18.18%
INCOME STATEMENTS
Revenue$ 1,720,000
Revenue Per Share$ 0.0289
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio9.20
Leverage Ratio1.70
Quick Ratio9.10
Long Term Debt To Capital0.13
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 2,442,039
Price to Sales32.84
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book0.70
Price To Cash Flow-1.60
PE Low Last 5 Years0.00
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-24.77
Return on Equity-38.14
Return on Capital-33.52

Century Therapeutics Inc. (IPSC) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOGregory Russotti
Employees188
Last Audit-
CIK0001850119
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address3675 Market Street
Philadelphia, PA 19104
Websitehttps://www.centurytx.com
Facsimile-
Telephone+1 267 817-5790
Email-


Your Recent History
NASDAQ
IPSC
Century Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.